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What Is Organ on a Chip Technology?
The term organ on a chip is used to describe the latest stage of development of in vitro cell culture technology. Figure 26 .1 shows its steady development since the 1960s. Each step forward has improved our ability to model human-clinical response to new drugs or therapies and has enabled safety risk assessment of existing cosmetics, personal care products, or other chemicals in the environ ment. Scientific evidence that the predictive power of in vitro tests is superior to the use of animals will trigger a major shift in the way that medical research, in many areas, is carried out. In this emerging field, some researchers also refer to organ on a chip as a microphysiological system. As yet, there are few agreed upon standards or definitions for the latest developments . (Vinci et al., 2011) .
Organoids. (Ramachandran et al., 2015 (Yoon et al., 2015) . (Haycock, Ahluwalia and Wilkinson, 2014) . ( Chandrasekera and Pip pin, 2014; Cook, Clerk and Sugden, 2009; Mestas and Hughes, 2004; Potashkin, Blume and Runkle, 2011) .
Microphysiological system (MPS
The choice to use animal cells is often driven by convenience rather than scientific reasons for further discussion see Redmond, 2019, (Eglen, 2017) . There is also a growing body of evidence that perfu sion (flow) of media over or through the cells produces a better prediction of IC50 (half maximal inhibitory concentration) levels of drug toxicity than static medium (Davidge and Bishop, 2017 (Park and Shuler, 2003) , which was closely followed by Arti Ahluwalia at the University of Pisa (Ahluwalia, 2004) ( Clerk and Villien, 2017 (Taylor et al., 2008 (Innovate UK, 2015) . The current worldwide market for animal testing is estimated to be in ex cess of us$30 billion (Bottini and Hartung, 2010 ) 
